Mesentech

📍 Vancouver, Canada🗓 Founded 2018👥 13 employees💰 Last funded Feb 2022
Biotechnology🌐 mesentech.com
Website LinkedIn
Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action. MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2018
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Canada
1
Frequently asked questions
Who invested in Mesentech?
Mesentech has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Mesentech last raise funding?
The most recent investment in Mesentech recorded on gritt.io was in February 2022.
When was Mesentech founded?
Mesentech was founded in 2018.
What industry is Mesentech in?
Mesentech operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Mesentech based?
Mesentech is headquartered in Vancouver, Canada.